Why, on earth, would a naturally-derived oil used as a treatment and supplement be classified a Schedule 1 drug by Drug Enforcement Agency (DEA)? It seems that cannabis advocates have a new reason to fight against a potential CDB oil ban.
DEA’s reclassification has many wondering, pissed and angry at the same time. According to this agency, CBD oil is now to be considered a Schedule 1 substance.
The Drug Enforcement Administration, the United States federal agency tasked with regulating and policing controlled substances is part of the executive body of the government and has the power to police and regulate drugs in this nation.
Considering the freaking announcement as made tangible through an issue of the new ruling Wednesday on December 13, 2016, the efficacy will be apparent on January 13, 2017, a month after.
Here in Ganjly, we are very glad to have shared about cannabidiol oil and the benefits it can bring specially to persons with multiple sclerosis, epilepsy and cancer. The CBD oil does not contain psychoactive component, which means it doesn’t get you high.
The oil can be in the form of capsule or in a liquid in a bottle, which also has topical uses, considering that it can also bring relief to certain skin condition.
According to the pro-medical marijuana organization California NORML, CBD oil has benefits to patients who have been suffering from certain conditions as proven in medical records and various research.
CBD has nonetheless long been known to have useful anti-spasmodic, anti-epileptic, anti-anxiety, and anti-psychotic properties.
A famous neurosurgeon, Dr. Sanjay Gupta, has openly advocated for medical marijuana, despite being initially “brainwashed” by the government.
Perhaps, the thing that has made this oil gained certain form of popularity, if not notoriety, these days is because of its relativity with marijuana, which is a Schedule 1 drug. In the federal level in the United States, marijuana is illegal.
Although states such as Alaska, Colorado, Oregon and California that have made marijuana legal for medical and recreational uses may have certain advantages compared to other states with the new ruling, the makers of CDB oil, even if their HQ’s are in the mentioned states may have to abide by the new ruling.
The DEA CBD Oil Ruling
The Schedule 1 status of marijuana, specifically, cannabis sativa and other cannabis plants has long been a point of contention between much of the public advocating for the herbal plant and the DEA. Heated debates are focused on the use of marijuana for medicinal purposes.
The new ruling is a poignant one, albeit distressing for cannabis oil manufacturers, which would require them to update their registration to the new code 7350 by January 13, 2017.
Considering that CBD oil is specifically designed to be a medicinal product and a dietary supplement, the question on the new ruling provides ambiguity to the public and about the status of the product. Though the DEA made a clarification that since it is derived from a Schedule 1 drug, the association of CBD oil to marijuana is a clarification of existing statutes.
The United Nations Conventions on international drug control treats extracts from the cannabis plant somewhat differently than marihuana or tetrahydrocannabinols. The creation of a new drug code in the DEA regulations for marihuana extracts will allow for more appropriate accounting of such materials consistent with treaty provisions.
It appears then that CBD oil is being charged because of its association to a federally-banned drug and the patients who have relied on this oil for medicinal and dietary purpose would suffer.
What should be noted though is that CBD oil is derived from a compound that does not produce a mind-altering state. Medical case studies suggest that CBD oil indeed has an “accepted medical use.”
But the DEA wanted to point out about the new ruling as its way to derive an effective implementation of a new tracking system.
The creation of this new drug code in the DEA regulations for marihuana extracts allows for more appropriate accounting of such materials consistent with treaty provisions. Such marihuana Start Printed Page 90196extracts remain in Schedule I. Entities registered to handle marihuana (under drug code 7360) that also handle marihuana extracts, will need to apply to modify their registrations to add the new drug code 7350 to their existing DEA registrations and procure quotas specifically for drug code 7350 each year.
As reported by Inquistr, the new CBD oil ruling could bring ambiguity to the situations in the CBD oil industry, especially the beneficiaries. But the ruling may have varying effects in various states, especially those with legal cannabis status.
The legal analysis goes on to explain that the DEA is not permitted to interfere with “legal state licensed cannabis business” and that the DEA has been de-funded from “pursuing any enforcement of their archaic interpretation of the Controlled Substances Act (CSA) in legal states.”